Literature DB >> 15935333

Kainate-activated currents in the ventral tegmental area of neonatal rats are modulated by interleukin-2.

Jiang-Hong Ye1, Steven S Zalcman, Liang Tao.   

Abstract

Interleukin (IL)-2 is a potent modulator of neurotransmission and neuronal development in the mesolimbic and mesostriatal systems. It is also implicated in pathologies (including schizophrenia, Parkinson's disease, autism, cognitive disorders) that are linked with abnormalities in these systems. Since the kainate receptor plays an essential role in mesolimbic neuronal development and excitability, we examined the effects of physiologically relevant concentrations of IL-2 on kainate-activated current (I(KA)) in voltage-clamped neurons freshly isolated from the ventral tegmental area (VTA) of 3- to 14-day-old rats. IL-2 (0.01-10 ng/ml) alone had no effect on membrane conductance. When co-applied with kainate, IL-2 significantly decreased I(KA). IL-2 (2 ng/ml) shifted the kainate concentration-response curve to the right in a parallel manner, significantly increasing the EC(50) without changing the maximal I(KA). IL-2 inhibition of I(KA) was voltage-dependent, being greater at negative potentials. IL-2 did not alter the reversal potential. These findings suggest that IL-2 potently modulates kainate receptors of developing mesolimbic neurons. We suggest that IL-2 plays a role in the excitability of developing neurons in the mesolimbic system. Inasmuch as increased I(KA) is associated with excitotoxicity, coupled with the present observation that IL-2 inhibits I(KA), we suggest an adaptive role for IL-2 in limiting excitotoxicity in the developing brain. IL-2 might thus be required for normal cell development in the mesolimbic and mesostriatal systems.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15935333     DOI: 10.1016/j.brainres.2005.05.016

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism--effects of medication.

Authors:  Robert D Oades; Maria R Dauvermann; Benno G Schimmelmann; Markus J Schwarz; Aye-Mu Myint
Journal:  Behav Brain Funct       Date:  2010-05-28       Impact factor: 3.759

2.  Spinal injection of IL-2 or IL-15 alters mechanical and thermal withdrawal thresholds in rats.

Authors:  Juan P Cata; Han-Rong Weng; Patrick M Dougherty
Journal:  Neurosci Lett       Date:  2008-03-29       Impact factor: 3.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.